Jul 012024
Drug Name |
Active Ingredient(s) |
Approval Date |
FDA-Approved Use on Approval Date |
Press Release |
Drug Trials Snapshot |
| Ohtuvayre | ensifentrine | 6/26/2024 | To treat chronic obstructive pulmonary disease | ||
| Piasky | crovalimab-akkz | 6/20/2024 | To treat paroxysmal nocturnal hemoglobinuria | ||
| Sofdra | sofpironium | 6/18/2024 | To treat primary axillary hyperhidrosis | ||
| Iqirvo | elafibranor | 6/10/2024 | To treat primary biliary cholangitis in combination with ursodeoxycholic acid | ||
| Rytelo | imetelstat | 6/6/2024 | To treat low- to intermediate-1 risk myelodysplastic syndromes |
Sorry, the comment form is closed at this time.